| Term 
 | Definition 
 
        | Anti-metabolite (hypoxanthine mimicker) that inhibits PRPP aminotransferase -inhibit de novo purine synth *catalyzed by HGPRT Works by (-) feedback of PRPP amidotransferase *metabolized by xanthine oxidase (use allopurinol) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-metabolite (inhibits DHFR) thus inhibit purine and thymidylate synthesis -Gets polyglutamated to activate (^ anti-thym synth and keeps it in the cell) *Leucovorin used to rescue cells Contra: Extra water mass |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-metabolite (hypoxanthine mimicker) that inhibits PRPP aminotransferase -inhibit de novo purine synth *catalyzed by HGPRT incorporated into DNA and RNA *Tumor lysis syndrome -xanthine oxidase (Tx: allopurinol) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Purine anti-metabolite -phosphorylated intracellularly to triphos, incorporated into DNA and causes chain termination *activates apoptosis Tx: CLL |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pyrimidine antimetabolite -has to be phorsphorylated -in the presence of THF binds to thymidylate synthase and traps enzyme in intermediate step *enhances toxicity with leucovorin *radiation sensitizer |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pyrimidine anti-metabolite used in AML -must be phosphorylated -Incorporated into DNA and inhibits DNA polymerase (only effective during S-phase)   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pyrimidine anti-metabolite -phosphorylated -Inhibits ribonucleotide reductase, causing depletion of dNTP pool -Incorporated into DNA causing strand termination *Potent radiosensitizer and shouldn't be used with radiotherapy |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antimetabolite -Active by itself -Inhibits ribonucleotide reductase, depleting dNTP, arresting cells @ G1/S (more sensitive to radiation) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antibiotic anti-cancer intercalates into G-C rich regions, can inhibit DNA synth *produces free-radicals |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antibiotic Anti-Cancer G-C rich regions, depression DNA, RNA, & protein synth *Lowers Ca2+ in pts with hypercalcemia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anthracycline antibiotic Anti-Cancer Stabilizes topoisomerase II & generates free radicals (^ apoptosis) *can turn pee bright red Contra: Cardiac dx (has cardiac toxicity) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anthracycline Antibiotic anti-Cancer Stabilizes topoisomerase II & generates free radicals (^ apoptosis) *dont use with impaired liver   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antracycline derivative antibiotic Anti-Cancer -inhibit topoisomerase II *less nausea and vomiting than doxo daunorubicin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antracycline derivative antibiotic Anti-Cancer -inhibit topoisomerase II (limited free radical production) *less nausea and vomiting than doxo daunorubicin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antibiotic Anti-Cancer -DNA binding and DNA scission (binds Fe++) **may lead to pulmonary fibrosis (due to low bleomycin hydrolase in lung and skin..hyperpigmentation) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antibiotic anti-CA -Reduced in hypoxic environments (produces free radicals) -Causes cross-links |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-mitotic anti-CA -Bind B-tubulin and block polymerization with a-tubulin (causing depolymerization)   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Vinca-alkaloid treats teste tumors causing neutropenia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tx ped leukemias and breast CA causing *Peripheral Neurotoxicity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-mitotic anti-CA -promotes polymerization of microtubules (forms abnormal structures)- G2/M *^ expression of P-glycoprotein=resistance |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-mitotic anti-CA -promotes polymerization of microtubules (forms abnormal structures)- G2/M *^ expression of P-glycoprotein=resistance |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Cancer *bind and trap DNA topoisomerase II |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Cancer *bind and trap DNA topoisomerase II |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Cancer Topoisomerase I inhibitors *causes double stranded break when rep fork catches it Renal Clearance |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Cancer Topoisomerase I inhibitors *causes double stranded break when rep fork catches it Prodrug |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Some lymphoid tumors lack ability to synth L-asparagine *can cause allergic rxn |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nitrogen Mustard (alkylating agent) -Forms cross-links |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nitrogen Mustard (alkylating agent) -Forms cross-links *requires metabolic activation in liver Sfx: hemmorhagic cystitis (by acrolein) *Use Mesna |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nitrogen Mustard (alkylating agent) -Forms cross-links *designed derivative |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Orally active Nitrogen Mustard (alkylating agent) -Forms cross-links Sfx: GI upset and hepatotoxicity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Orally administered Alkyl sulfunate |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nitrosurea anti-CA used for brain tumors (lipophilic) *can cause severe delayed myelosuppression |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nitrosurea anti-CA used for brain tumors (lipophilic) *can cause severe delayed myelosuppression |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nitrosurea anti-CA used for brain tumors (lipophilic) *can cause severe delayed myelosuppression and delayed renal failure in children |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nitrosurea that methylates @ O-6 (not N7) -monofxnal, can be carcinogenic |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anticancer, requires activation in liver makes MTIC kills cells in all phases of cell cycle |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | AntiCancer causes DNA methylation, plasma t1/2= 7 mins *monofxnal=highly carcinogenic, can cause infertility |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Platinum complex -undergo sequential aquation, causes intrastrand adducts Sfx:Ototoxicity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Platinum complex -undergo sequential aquation, causes intrastrand adducts Sfx:Ototoxicity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Steroidal antiestrogen, binds E2R causing downregulation 2nd line tx |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | GnRH superagonist- inhibits gonadotropin release |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | GnRH superagonist- inhibits gonadotropin release |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-steroidal androgen receptor blocker |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | all-trans retinoic acid APML |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tyrosine Kinase inhib CML (Bcr-Abl) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | EGFR Tyrosine Kinase inhib NSCLC |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | EGFR Tyrosine Kinase inhib  SCLC |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Competitive antag at EGFR |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Binds CD20 on B-cells, causing death |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | prevents degradation of pro-apoptotic factors |  | 
        |  |